Oncolytic virus therapy is an exciting and increasingly recognized discipline in cancer research. Although the link between the virus and cancer regression was recognized in the early 20th century, viral therapy was used to attack and destroy cancer cells, and until recently, advanced genetic engineering techniques were developed.
This report elaborates the market size, market characteristics, and market growth of the OV Therapy industry, and breaks down according to the type, application, and consumption area of OV Therapy. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for OV Therapy in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global OV Therapy market covered in Chapter 13:
Cold Genesys
Transgene SA
Vyriad
Oncolys BioPharma
Sorrento Therapeutics
Targovax
Genelux Corporation
Oncolytics Biotech
SillaJen Biotherapeutics
PsiOxus Therapeutics
Viralytics
Lokon Pharma
TILT Biotherapeutics
Amgen

In Chapter 6, on the basis of types, the OV Therapy market from 2015 to 2025 is primarily split into:
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

In Chapter 7, on the basis of applications, the OV Therapy market from 2015 to 2025 covers:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025